SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq:MEND) today announced positive initial results from a single-center study of neurovascular aneurysms treated with Micrus Endovascular’s Cerecyte® microcoils indicating an excellent safety profile and a recanalization rate below historical published rates for bare platinum coils. Results from the study, authored by Martin Bendszus, MD, from the Department of Neuroradiology, University of Würzberg, Germany, and László Solymosi, MD, were published in the November/December 2006 issue of peer-reviewed American Journal of Neuroradiology (www.ajnr.org). The article is available on the Investor Relations section of the Company’s Web site at www.micruscorp.com.
